2012 annual financial data

PTC Therapeutics, Inc. 2012 Net margin

PTC Therapeutics, Inc. 2012 net margin with verified reported values.

Direct answer

Net margin was -91.16%.

Operating income was -26,808,181 USD and net income was -26,235,102 USD.
Operating cash flow was -47,927,791 USD.

Get free PTC Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
28,779,078 USD
Operating income
-26,808,181 USD
Net income
-26,235,102 USD
Operating cash flow
-47,927,791 USD